Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective Review
Restricted accessLetterFirst published online July, 2025
Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective Review
SimpsonEL, PappKA, BlauveltA, et al.Efficacy and safety of upadacitinib in patients with moderate to severe atopic dermatitis: Analysis of follow-up data from the measure up 1 and measure up 2 randomized clinical trials. JAMA Dermatol. 2022; 158(4):404–413; doi: 10.1001/jamadermatol.2022.0029
2.
SilverbergJI, de Bruin-WellerM, BieberT, et al.Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD up study results. J Allergy Clin Immunol. 2022; 149(3):977–987.e14; doi: 10.1016/j.jaci.2021.07.036
3.
GargiuloL, IbbaL, PiscazziF, et al.Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: A 52-week retrospective study. J Eur Acad Dermatol Venereol. 2024; 38(2):e152–e154; doi: 10.1111/jdv.19507
4.
ChiricozziA, OrtoncelliM, SchenaD, et al.Long-term effectiveness and safety of upadacitinib for atopic dermatitis in a real-world setting: An interim analysis through 48 weeks of observation [published correction appears in Am J Clin Dermatol. 2023 Aug 19]. Am J Clin Dermatol. 2023; 24(6):953–961; doi: 10.1007/s40257-023-00798-0
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
